These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


169 related items for PubMed ID: 11045267

  • 1. Serum level of vascular endothelial growth factor is influenced by erythropoietin treatment in peritoneal dialysis patients. (Grupo de Estudios Peritoneales de Madrid).
    del Peso G, Selgas R, Bajo MA, Fernández de Castro M, Aguilera A, Cirugeda A, Jiménez C.
    Adv Perit Dial; 2000; 16():85-9. PubMed ID: 11045267
    [Abstract] [Full Text] [Related]

  • 2. Vascular endothelial growth factor (VEGF) levels in peritoneal dialysis effluent.
    Selgas R, del Peso G, Bajo MA, Molina S, Cirugeda A, Sánchez-Tomero JA, Castro MJ, Castro MA, Vara F.
    J Nephrol; 2001; 14(4):270-4. PubMed ID: 11506249
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up.
    Zweers MM, Struijk DG, Smit W, Krediet RT.
    J Lab Clin Med; 2001 Feb; 137(2):125-32. PubMed ID: 11174469
    [Abstract] [Full Text] [Related]

  • 4. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
    Aroeira LS, Aguilera A, Selgas R, Ramírez-Huesca M, Pérez-Lozano ML, Cirugeda A, Bajo MA, del Peso G, Sánchez-Tomero JA, Jiménez-Heffernan JA, López-Cabrera M.
    Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin-6: relationship with peritoneal transport.
    Rodrigues A, Martins M, Santos MJ, Fonseca I, Oliveira JC, Cabrita A, Melo e Castro J, Krediet RT.
    Adv Perit Dial; 2004 Nov; 20():8-12. PubMed ID: 15384786
    [Abstract] [Full Text] [Related]

  • 6. Intraperitoneal vascular endothelial growth factor C level is related to peritoneal dialysis ultrafiltration.
    Yang WS, Tsai TJ, Shih CL, Huang JW, Chuang HF, Chen MH, Fang CC.
    Blood Purif; 2009 Nov; 28(1):69-74. PubMed ID: 19439926
    [Abstract] [Full Text] [Related]

  • 7. Factors influencing peritoneal transport parameters during the first year on peritoneal dialysis: peritonitis is the main factor.
    del Peso G, Fernández-Reyes MJ, Hevia C, Bajo MA, Castro MJ, Cirugeda A, Sánchez-Tomero JA, Selgas R.
    Nephrol Dial Transplant; 2005 Jun; 20(6):1201-6. PubMed ID: 15827050
    [Abstract] [Full Text] [Related]

  • 8. Effects of human recombinant erythropoietin on inflammatory status in peritoneal dialysis patients.
    Aguilera A, Bajo MA, Díez JJ, Ruiz-Caravaca ML, Vicenta Cuesta M, Alvarez V, Codoceo R, Selgas R.
    Adv Perit Dial; 2002 Jun; 18():200-5. PubMed ID: 12402619
    [Abstract] [Full Text] [Related]

  • 9. Inflammation, peritoneal transport, and response to erythropoietin in peritoneal dialysis patients.
    Pilkey RM, Morton AR, Iliescu EA.
    Adv Perit Dial; 2001 Jun; 17():153-7. PubMed ID: 11510266
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
    Rodrigues AS, Martins M, Korevaar JC, Silva S, Oliveira JC, Cabrita A, Castro e Melo J, Krediet RT.
    Am J Nephrol; 2007 Jun; 27(1):84-91. PubMed ID: 17284895
    [Abstract] [Full Text] [Related]

  • 11. The effect of oxidative stress inhibition with trimetazidine on the peritoneal alterations induced by hypertonic peritoneal dialysis solution.
    Günal AI, Celiker H, Ustundag B, Akpolat N, Dogukan A, Akcicek F.
    J Nephrol; 2003 Jun; 16(2):225-30. PubMed ID: 12768069
    [Abstract] [Full Text] [Related]

  • 12. Circulating levels of vascular endothelial growth factor in patients with oral squamous cell carcinoma.
    Shang ZJ, Li JR, Li ZB.
    Int J Oral Maxillofac Surg; 2002 Oct; 31(5):495-8. PubMed ID: 12418564
    [Abstract] [Full Text] [Related]

  • 13. Plasma levels of vascular endothelial growth factor in patients with acromegaly.
    Nagai Y, Ando H, Nohara E, Yamashita H, Takamura T, Kobayashi K.
    Horm Metab Res; 2000 Aug; 32(8):326-9. PubMed ID: 10983629
    [Abstract] [Full Text] [Related]

  • 14. Vascular endothelial growth factor in peritoneal dialysis patients.
    Jovanović N, Božinovski SŽ, Krstić S, Obrenović R, Trbojević-Stanković J, Stojimirović B.
    Clin Lab; 2014 Aug; 60(10):1695-701. PubMed ID: 25651716
    [Abstract] [Full Text] [Related]

  • 15. Growth factors VEGF and TGF-beta1 in peritoneal dialysis.
    Zweers MM, de Waart DR, Smit W, Struijk DG, Krediet RT.
    J Lab Clin Med; 1999 Aug; 134(2):124-32. PubMed ID: 10444025
    [Abstract] [Full Text] [Related]

  • 16. Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancer.
    Feldman AL, Tamarkin L, Paciotti GF, Simpson BW, Linehan WM, Yang JC, Fogler WE, Turner EM, Alexander HR, Libutti SK.
    Clin Cancer Res; 2000 Dec; 6(12):4628-34. PubMed ID: 11156212
    [Abstract] [Full Text] [Related]

  • 17. Effect of multimodality therapy on circulating vascular endothelial growth factor levels in patients with oesophageal cancer.
    McDonnell CO, Harmey JH, Bouchier-Hayes DJ, Walsh TN.
    Br J Surg; 2001 Aug; 88(8):1105-9. PubMed ID: 11488797
    [Abstract] [Full Text] [Related]

  • 18. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity.
    Robak E, Woźniacka A, Sysa-Jedrzejowska A, Stepień H, Robak T.
    Eur Cytokine Netw; 2001 Aug; 12(3):445-52. PubMed ID: 11566625
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of peritoneal transport properties at onset of peritoneal dialysis and longitudinal follow-up.
    Clerbaux G, Francart J, Wallemacq P, Robert A, Goffin E.
    Nephrol Dial Transplant; 2006 Apr; 21(4):1032-9. PubMed ID: 16364990
    [Abstract] [Full Text] [Related]

  • 20. Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma.
    Strizzi L, Catalano A, Vianale G, Orecchia S, Casalini A, Tassi G, Puntoni R, Mutti L, Procopio A.
    J Pathol; 2001 Apr; 193(4):468-75. PubMed ID: 11276005
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.